{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:38:02Z","timestamp":1760146682342,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slovenian Research and Innovation Agency (ARIS)","award":["P3-0289"],"award-info":[{"award-number":["P3-0289"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The tumour microenvironment (TME) plays an important role in the development and progression of cancer and it differs among lymphomas, both with respect to the composition and quantity of specific tumour-infiltrating immune cells (TICs), such as FoxP3+ regulatory T cells (Tregs). The role of FoxP3+ Tregs in the TME of peripheral T-cell lymphomas (PTCLs) is complex, and their impact on overall survival (OS) remains unclear. Consequently, we aim to evaluate and compare the FoxP3+ cell quantity in nodal PTCLs and reactive lymph nodes (LNs), with a focus on investigating their impact on OS. Methods: excisional lymph node (LN) biopsies from 105 nodal PTCLs and 17 reactive LNs are immunohistochemically stained for FoxP3. Visual scoring of FoxP3+ cells is performed, and different cut-off values are used to evaluate the impact of FoxP3+ cell quantity on OS. Results: FoxP3+ cells are present in the TME of all cases, except for four cases where FoxP3+ is expressed in lymphoma cells. Lower FoxP3+ cell quantities are observed in certain nodal PTCL subtypes compared to reactive LNs. Patients with high FoxP3+ cell quantities show improved OS. However, the FoxP3+ cell quantity is not confirmed as an independent prognostic biomarker. Conclusions: these findings underscore the promise of FoxP3+ cell quantities as added value in prognosis and highlight the potential benefits of Treg-stimulating therapies in PTCLs.<\/jats:p>","DOI":"10.3390\/cancers16234011","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T03:50:57Z","timestamp":1733111457000},"page":"4011","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FoxP3+ Regulatory T-Cell Quantities in Nodal T-Follicular Helper Cell Lymphomas and Peripheral T-Cell Lymphomas Not Otherwise Specified and Their Impact on Overall Survival"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8230-8707","authenticated-orcid":false,"given":"Eva","family":"Erzar","sequence":"first","affiliation":[{"name":"Department of Cytopathology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"},{"name":"Medical Faculty, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Sch\u00f6nbeinstrasse 40, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-2054","authenticated-orcid":false,"given":"Janja","family":"Ocvirk","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia"},{"name":"Division of Medical Oncology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Gr\u010dar Kuzmanov","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-1470","authenticated-orcid":false,"given":"Lu\u010dka","family":"Bolte\u017ear","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia"},{"name":"Division of Medical Oncology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-6596","authenticated-orcid":false,"given":"Veronika Kloboves","family":"Prevodnik","sequence":"additional","affiliation":[{"name":"Department of Cytopathology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"},{"name":"Medical Faculty, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-3627","authenticated-orcid":false,"given":"Gorana","family":"Ga\u0161ljevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Oncology Ljubljana, Zalo\u0161ka Cesta 2, 1000 Ljubljana, Slovenia"},{"name":"Medical Faculty, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/14712598.6.7.671","article-title":"The tumour microenvironment and implications for cancer immunotherapy","volume":"6","author":"Petrulio","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcancer.2013.11.004","article-title":"The microenvironment in T-cell lymphomas: Emerging themes","volume":"24","author":"Gaulard","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000502912","article-title":"Lymphomas and Their Microenvironment: A Multifaceted Relationship","volume":"86","author":"Menter","year":"2019","journal-title":"Pathobiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-319-99716-2_3","article-title":"Tumor Microenvironment in T-Cell Lymphomas","volume":"Volume 176","author":"Querfeld","year":"2019","journal-title":"T-Cell and NK-Cell Lymphomas"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00432-020-03398-1","article-title":"Prognostic role of regulatory T cells in lymphoma: A systematic review and meta-analysis","volume":"146","author":"Peng","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-003-0444-1","article-title":"Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells","volume":"53","author":"Wei","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39658","DOI":"10.18632\/oncotarget.17340","article-title":"Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: A meta-analysis","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shang, B., Liu, Y., Jiang, S.J., and Liu, Y. (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: A systematic review and meta-analysis. Sci. Rep., 5.","DOI":"10.1038\/srep15179"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Xu, P., Fan, W., Zhang, Z., Wang, J., Wang, P., Li, Y., and Yu, M. (2017). The clinicopathological and prognostic implications of FoxP3+ regulatory T cells in patients with colorectal cancer: A meta-analysis. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00950"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.24989","article-title":"High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients","volume":"126","author":"Frey","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.11702","article-title":"Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma","volume":"93","author":"Tzankov","year":"2008","journal-title":"Haematologica"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: Association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/annonc\/mdp056","article-title":"Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK\/T-cell lymphoma","volume":"20","author":"Kim","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2147\/CMAR.S244176","article-title":"A new immunological prognostic model based on immunohistochemistry for extranodal natural killer\/T-cell lymphoma patients after non-anthracycline-based chemotherapy","volume":"12","author":"Lam","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190701824536","article-title":"Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis","volume":"49","author":"Lee","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7150\/ijbs.7.1027","article-title":"Circulating and tumor-infiltrating Foxp3+ regulatory T cell subset in chinese patients with extranodal NK\/T cell lymphoma","volume":"7","author":"Peng","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jcp-2023-208932","article-title":"Correlation of low numbers of intratumoral FOXP3+ cells with worse progression-free survival in angioimmunoblastic T cell lymphoma","volume":"77","author":"Liu","year":"2024","journal-title":"J. Clin. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03009734.2018.1555195","article-title":"Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: No correlation with survival","volume":"124","author":"Lundberg","year":"2019","journal-title":"Ups. J. Med. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2353\/ajpath.2010.100150","article-title":"Short Communication Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma","volume":"177","author":"Bruneau","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1309\/L65GWEQ803PP6VX1","article-title":"Evaluation of FoxP3 Expression in Peripheral T-Cell Lymphoma","volume":"130","author":"Bonzheim","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","article-title":"FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma","volume":"19","author":"Roncador","year":"2005","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/his.12885","article-title":"FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: Clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides","volume":"68","author":"Satou","year":"2016","journal-title":"Histopathology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PAI.0b013e318225189f","article-title":"Peripheral T-cell lymphoma with a regulatory T-cell phenotype: Report of a nodal and an extranodal case from Peru","volume":"20","author":"Beltran","year":"2012","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12308-014-0201-8","article-title":"Peripheral T cell lymphoma with a regulatory T cell phenotype: A Mexican case not associated with HTLV-1 virus infection","volume":"7","year":"2014","journal-title":"J. Hematopathol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Langerak","year":"2003","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404482","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"Langerak","year":"2007","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2559.2011.04097.x","article-title":"Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: A meta-analysis of 56 cases","volume":"60","author":"Tan","year":"2012","journal-title":"Histopathology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/23\/4011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:42:58Z","timestamp":1760114578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/23\/4011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":36,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cancers16234011"],"URL":"https:\/\/doi.org\/10.3390\/cancers16234011","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}